SPH Annual Audited Consolidated Financial Statements of “Sopharma” AD
Sofia, Bulgaria, 29 April 2025 – According to the requirements of art. 100n of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Consolidated Financial Statements,
| Data | Tytuł | Kurs | Zmiana |
|---|
2026-02-20 | SPH Notification for sales revenues for January 2026 | 8,50 | -1,18 |
2026-02-16 | SPH Notification for sale of treasury shares | 8,90 | -8,09 |
2026-02-13 | SPH Notification for sale of treasury shares | 10,00 | 0,00 |
2026-02-12 | SPH Notification for sale of treasury shares | 12,55 | -29,88 |
2026-02-11 | SPH Annual meeting with investors of "Sopharma" AD | 12,55 | 0,00 |
2026-02-11 | SPH Notification for sale of treasury shares | 12,55 | 0,00 |
2026-02-10 | SPH Notification for sale of treasury shares | 12,55 | 0,00 |
2026-02-09 | SPH Notification for sale of treasury shares | 12,55 | 0,00 |
2026-02-06 | SPH Notification for sale of treasury shares | 12,55 | 0,00 |
2026-02-05 | SPH Notification for sale of treasury shares | 12,55 | 0,00 |
